KORU Medical Systems, Inc.

NasdaqCM:KRMD Stock Report

Market Cap: US$184.3m

KORU Medical Systems Past Earnings Performance

Past criteria checks 0/6

KORU Medical Systems's earnings have been declining at an average annual rate of -50.6%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 6.5% per year.

Key information

-50.6%

Earnings growth rate

-50.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate6.5%
Return on equity-67.5%
Net Margin-37.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

KORU Medical Systems, Inc. (NASDAQ:KRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.10

Nov 16
KORU Medical Systems, Inc. (NASDAQ:KRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.10

Impressive Turnaround At KORU Medical

Nov 06

We're Interested To See How KORU Medical Systems (NASDAQ:KRMD) Uses Its Cash Hoard To Grow

Aug 29
We're Interested To See How KORU Medical Systems (NASDAQ:KRMD) Uses Its Cash Hoard To Grow

KORU Medical Systems, Inc. (NASDAQ:KRMD) Doing What It Can To Lift Shares

Jul 30
KORU Medical Systems, Inc. (NASDAQ:KRMD) Doing What It Can To Lift Shares

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

Feb 15
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Sep 21
We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

Jul 14
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Sep 27
We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Oct 27
Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Aug 14
Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Feb 22
Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

Jan 27
Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

Revenue & Expenses Breakdown

How KORU Medical Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:KRMD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2432-12215
30 Jun 2431-12205
31 Mar 2429-13206
31 Dec 2329-14206
30 Sep 2329-8206
30 Jun 2329-8206
31 Mar 2329-9215
31 Dec 2228-9215
30 Sep 2227-8214
30 Jun 2225-8204
31 Mar 2224-6183
31 Dec 2123-5182
30 Sep 2121-4162
30 Jun 2121-3151
31 Mar 2123-3141
31 Dec 2024-1121
30 Sep 20260121
30 Jun 20270111
31 Mar 20251101
31 Dec 19231101
30 Sep 19210101
30 Jun 1919090
31 Mar 1918090
31 Dec 1817180
30 Sep 1818280
30 Jun 1817280
31 Mar 1816180
31 Dec 1716180
28 Feb 1712-180
30 Nov 1613070
31 Aug 1613070
31 May 1613160
29 Feb 1612160
30 Nov 1512160
31 Aug 1512150
31 May 1511150
28 Feb 1511150
30 Nov 1410140
31 Aug 1410140
31 May 149140
28 Feb 149140

Quality Earnings: KRMD is currently unprofitable.

Growing Profit Margin: KRMD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: KRMD is unprofitable, and losses have increased over the past 5 years at a rate of 50.6% per year.

Accelerating Growth: Unable to compare KRMD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: KRMD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).


Return on Equity

High ROE: KRMD has a negative Return on Equity (-67.51%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:55
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

KORU Medical Systems, Inc. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Neil ChatterjiB. Riley Securities, Inc.
Kyle BauserB. Riley Securities, Inc.
Kyle RoseCanaccord Genuity